1. nomaam4565
2. dianamoonblade1
3. pierceton
4. SugarDaddy
5. nshsn8vjkdpyvqf
1.SugarDaddy 10/18/2017
2.pierceton 01/26/2018
AbbVie Reports Full-Year and Fourth-Quarter 2017 Financial Results
3.dianamoonblade1 02/18/2018
AbbVie Announces New Phase 2 Data for Upadacitinib Showing Clinical and Endoscopic Outcomes in Crohn's Disease at 52 Weeks
4.nomaam4565 01/29/2018
$144 PT
5.pierceton 02/18/2018
AbbVie Presents New Positive Late-Breaking Data from Two Phase 3 Psoriasis Trials of Risankizumab at the 2018 American Academy of Dermatology Annual Meeting
6.dianamoonblade1 02/05/2018
Granted orphan drug designation by the FDA for Imbruvica for the treatment of gastric cancer, including gast…
7.SugarDaddy 04/05/2018
AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Samsung Bioepis
8.pierceton 01/26/2018
Sees FY18 EPS of $7.33-7.43 from $6.37-6.57
9.pierceton 01/26/2018
ABBV leads the way today as the best performing large cap stock, closing up 13.77%.
10.nomaam4565 05/24/2018
Goldman Sachs removes from conviction buy list
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW